RiboMed Receives Three Additional Patents for Disease Diagnostics…
RiboMed Biotechnologies Inc., a leading Epigenetics-Based Diagnostics company, today announced that the U.S. Patent and Trademark Office has issued three additional patents covering the use of their…(PRWeb December 05, 2012)Read the full story at …
RiboMed Receives Three Additional Patents for Disease Diagnostics… Read Post »
